What are the potential ethical issues to be considered for the research participants and

Similar documents
UNIVERSITY OF WISCONSIN HOSPITAL AND CLINICS DEPARTMENT OF PHARMACY SCOPE OF PATIENT CARE SERVICES FY 2017 October 1 st, 2016

Quality Management Building Blocks

MEDICATION THERAPY MANAGEMENT. MemberChoice FORMULARY MANAGEMENT MEDICATION THERAPY MANAGEMENT (MTM) SPECIALTY DRUG MANAGEMENT

Draft Private Health Establishment Policy

Nova Scotia Drug Information System

Primary & Secondary Care Interface Issues. Safety In Practice Learning Session 4 27th June 2016

GUIDELINES ON REGIONAL IMMEDIATE DISCHARGE DOCUMENTATION FOR PATIENTS BEING DISCHARGED FROM SECONDARY INTO PRIMARY CARE

Discharge from hospital

Moving the Green Medicines Bag from the Safety Agenda to QIPP

Harrogate and District NHS Foundation Trust. Information on Pre- Registration Pharmacist Training

PHCY 471 Community IPPE. Student Name. Supervising Preceptor Name(s)

Medicine Reconciliation FREQUENTLY ASKED QUESTIONS NATIONAL MEDICATION SAFETY PROGRAMME

Gathering and Using Evidence & Data to Demonstrate Improvements Within Your Care Home

Introduction. Singapore and its Quality and Patient Safety Position. Singapore 2004: Top 5 Key Risk Factors. High Body Mass

W e were aware that optimising medication management

South East London Interface Prescribing Policy including the NHS and Private Interface Prescribing Guide

Frail and Elderly Assessment Support Team (FEAST)

CLINICAL SERVICES OVERVIEW

MEDICARE CCLF ANALYTICS: MEDICARE ANALYTICS DATA ENGINE (MADE)

Solution Title Impact on readmission rates of psychiatric patients following pharmacist discharge counseling in a community hospital

Maternity benefit 2018

JOB DESCRIPTION. Progressive: A learning organization, encouraging innovation and continuous improvement.

2) The percentage of discharges for which the patient received follow-up within 7 days after

Community Health Network of San Francisco Committee on Interdisciplinary Practice

Fast Facts 2018 Clinical Integration Performance Measures

All Wales Multidisciplinary Medicines Reconciliation Policy

Improving Diabetes Management in Care Homes within Swale CCG

The TTO Journey: How Much Of It Is Actually In Pharmacy?

2011 National NHS staff survey. Results from London Ambulance Service NHS Trust

2016 PHYSICIAN QUALITY REPORTING OPTIONS FOR INDIVIDUAL MEASURES REGISTRY ONLY

Visiting Professional Programme: HIV Pharmacy

CMS Proposed Rule. The IMPACT Act. 3 Overhaul Discharge Planning Processes to Comply With New CoPs. Arlene Maxim VP of Program Development, QIRT

AXIS. d t. i Ef f i c i e n c y D. CompCare Wellness Medical Scheme. Information and Benefit Guide Di s -C hem. tc a

Reconciliation of Medicines on Admission to Hospital

Strategies to Improve the Use of Medicines Standard Treatment Guidelines

Practice Tools for Safe Drug Therapy

Call for Posters. Deadline for Submissions: May 15, Washington, DC Gaylord National Harbor Hotel October 18 21, 2015

CPT only copyright 2014 American Medical Association. All rights reserved. 12/23/2014 Page 537 of 593

Quality Improvement and Patient Safety (QPS) Ratchada Prakongsai Senior Manager

Reference materials are provided with the criteria and should be used to assist in the correct interpretation of the criteria.

CAPE/COP Educational Outcomes (approved 2016)

Adopting Standardized Definitions The Future of Data Collection and Benchmarking in Alternate Site Infusion Must Start Now!

The Pharmacist Coalition for Health Reform

Medicines Reconciliation: Standard Operating Procedure

Test Content Outline Effective Date: December 23, 2015

PHARMACIST INDEPENDENT PRESCRIBING MEDICAL PRACTITIONER S HANDBOOK

A. Goals and Objectives:

Standard operating procedures: Health facility malaria committees

Commonwealth Nurses Federation. A Safe Patient. Jill ILIFFE Executive Secretary. Commonwealth Nurses Federation

Management of patients with TB/HIV Gunta Kirvelaite

Title: Climate-HIV Case Study. Author: Keith Roberts

PHARMACEUTICAL REPRESENTATIVE POLICY NOVEMBER This policy supersedes all previous policies for Medical Representatives

MINNESOTA. Downloaded January 2011

WPS Integrated Care Management Improving health, one member at a time

Definitions/Glossary of Terms

Cover for pregnancy and childbirth

Liberating the NHS: No decision about me, without me Further consultation on proposals to shared decision-making

Introduction. Singapore. Singapore and its Quality and Patient Safety Position 11/9/2012. National Healthcare Group, SIN

Is it possible to define the improved health outcome for the patient

Cornelia C. Campbell NU602 Fall 2011 Reflection Paper #5

Information shared between healthcare providers when a patient moves between sectors is often incomplete and not shared in timely enough fashion.

YORKSHIRE AND HUMBER CLINICAL PHARMACY BENCHMARKING

PCMH 2014 Recognition Checklist

UTILIZATION MANAGEMENT AND CARE COORDINATION Section 8

Patient-Centered Connected Care 2015 Recognition Program Overview. All materials 2016, National Committee for Quality Assurance

RYAN WHITE HIV/AIDS PROGRAM SERVICES Definitions for Eligible Services

Total Cost of Care Technical Appendix April 2015

17. Updates on Progress from Last Year s JSNA

Measure #46 (NQF 0097): Medication Reconciliation Post-Discharge National Quality Strategy Domain: Communication and Care Coordination

INTRODUCTION Reduce falls Improve patient outcomes Establish a baseline of falls in home care

MEDICARE CCLF ANALYTICS: MEDICARE ANALYTICS DATA ENGINE (MADE)

Welcome to the Agency for Health Care Administration (AHCA) Training Presentation for Managed Medical Assistance Specialty Plans

7 th Edition FACT-JACIE International Standards for Hematopoietic Cellular Therapy Product Collection, Processing, and Administration

EVOLENT HEALTH, LLC. Heart Failure Program Description 2017

CAH PREPARATION ON-SITE VISIT

Measure #46 (NQF 0097): Medication Reconciliation Post-Discharge National Quality Strategy Domain: Communication and Care Coordination

Institutional Handbook of Operating Procedures Policy

Implementation of STOPP/START criteria in different settings

Entry Level Assessment Blueprint Medical Assisting

AXIS. CompCare Wellness Medical Scheme. Information and Benefit Guide 2018

Elective Report Personal Learning Objectives and Reflections

Section Title. Prescribing competency framework Catherine Picton, Lead author

Essential Skills and Abilities Requirements for Admission, Promotion, and Graduation in the Pharmacy Program

NATIONAL HEALTHCARE AGREEMENT 2011

Admissions and Readmissions Related to Adverse Events, NMCPHC-EDC-TR

Colorado Board of Pharmacy Rules pertaining to Collaborative Practice Agreements

NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE SCOPE

CHARTER ON PATIENTS & HEALTH SERVICE PROVIDERS RIGHTS & RESPONSIBILITIES

IMPACT OF RN HYPERTENSION PROTOCOL

Ambulatory Care Unit SGH & Medical Ambulatory Care Unit DPOW

APPROACHES TO ENHANCING THE QUALITY OF DRUG THERAPY A JOINT STATEMENT BY THE CMA ANDTHE CANADIAN PHARMACEUTICAL ASSOCIATION

Indicators and descriptors and how they can be used. Hanne Herborg Director R&D Danish College of Pharmacy Practice

Specialised Services Service Specification: Inherited Bleeding Disorders

Penn Specialty Pharmacy Program mypennpharmacy bringing the Pharmacy to Patients

Emergency Readmission Audit

Clinical Pharmacist Renal

Quality ID #46 (NQF 0097): Medication Reconciliation Post-Discharge National Quality Strategy Domain: Communication and Care Coordination

1 Title Improving Wellness and Care Management with an Electronic Health Record System

Partnering with Pharmacists to Enhance Medication Management

21 March NHS Providers ON THE DAY BRIEFING Page 1

Transcription:

What are the potential ethical issues to be considered for the research participants and researchers in the following types of studies? 1. Postal questionnaires 2. Focus groups 3. One to one qualitative interviews 4. Non-participant observation 5. Extraction of data from written documentation 6. Controlled study of new health care service

1. Postal questionnaires The aim of this study is to assess the prevalence of adherence to antiretroviral treatment in HIV-infected patients and to evaluate factors associated with adherence. All HIV-treated patients, who attend the participating outpatient clinics during the study period, will be sent a questionnaire, to be completed and returned by post. The questionnaire consists of three parts: A demographic questionnaire, collecting data on gender, age, origin, homelessness, method of HIV transmission, viral load, drug or alcohol problems, and contacts with psychiatric health care. Medication Adherence Scale (9 item questionnaire) Motivation index (2 item scale)

2. Focus groups The aim of this study is to develop an understanding of the medicines information needs of women who have had a diagnosis of breast cancer. Six focus groups, each containing 7-12 participants, will be held with purposively selected women from a defined geographical area. Posters will be displayed in the outpatient clinic areas of the local hospital and hospice, and the researcher will personally invite women who attend her Medication Management Clinic. Women will be selected for inclusion because they are likely to have an opinion, and based on their age, their current medication (including complementary therapies), whether they are pre- or post-menopausal, whether they are/ever have been involved in a clinical trial, and whether they are or are not IT literate. The focus groups will be tape recorded, and an assistant will also take notes, to provide context for the tape and non-verbal communication within the group.

3. One to one qualitative interviews The aims of this study are to describe some of the types of prescribing decisions that cause a feeling of discomfort in secondary care prescribers and to explore why particular decisions are perceived to be uncomfortable by these prescribers. Potential participants will be sent a short questionnaire, which requests general information about the participant, relating to their grade, position, time employed in that position, department and their contact details. Participants for the interviews will be purposively selected from those who return the questionnaire, based on their grade and department. Prior to the interview, the participants will be asked to remember any instances where they have felt uncomfortable when making a prescribing decision, regardless of whether a prescription was actually issued or not. An interview will follow within two weeks, where the incident(s) will be discussed in-depth, followed by a less structured set of questions about their general perceptions about uncomfortable prescribing decisions.

4. Non-participant observation The aim of this study is to assess the aseptic technique, and consequent patient risk, of trained nurses who are preparing injections immediately prior to administration to patients in an intensive care unit and a special care baby unit. An observation form will be prepared, based on the standard operating procedures for the preparation of injections in Near Patient Areas. A non-participant observer will assess the nursing staff when they are preparing injections as part of their normal daily routine. Data to be collected will include the number of manipulations and calculations performed, a description of the immediate ward environment, the number of checks performed by other staff, whether the patient is immunocompromised, any potential contamination risk and any other potential for medication errors.

5. Extraction of data from written documentation The aim of this study is to assess the proportion of adverse drug reactions that could be attributed to inappropriate prescriptions in a sample of hospitalised elderly patients. All patients aged 65 years or over admitted to the acute geriatric and medical wards will be recruited. Patients who are admitted from their own homes, elderly person's homes, or nursing homes, and including both emergency and booked admissions, will be eligible. The following data will be collected for each patient: basic demographic information, drugs on admission, presenting complaint, previous medical history and known diagnoses, the results of biochemical tests or blood counts and other relevant tests carried out, on or shortly after, admission; and alterations to drug therapy whilst in hospital. All patients entering the study will be reviewed daily. Using the above data, inappropriate prescriptions (unnecessary drugs and those with absolute contra-indications), interacting drugs, adverse drug reactions and drug-related admissions will be identified.

6. Controlled study of new health care service The aim of this study is to assess the benefits of a new structured clinical pharmacy wardbased team to the patient, pharmacy department and ward staff. The new service involves a junior pharmacist and a pharmacy technician, with the support of a senior pharmacist, being based on the wards and providing a clinical pharmacy service during the normal working day (9am to 5pm). The current service involves a single pharmacist visiting the ward daily for 1-2 hours. The new service will be provided to two medical wards in the hospital and two other medical wards will continue to receive the current service, and act as controls. Data that will be collected will include the number, nature and outcome of recommendations made regarding prescriptions, the number of patients counselled, the time delay between prescription and supply of medication, the patients length of hospital admission and the satisfaction of doctors and nurses with the pharmacy services.